相关实验视频
Updated: Sep 20, 2025
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
16.0K
事实和希望:迈向黑色素瘤的下一个量子飞跃
Keith T Flaherty1, Andrew E Aplin2, Michael A Davies3
1Mass General Cancer Center, Boston, Massachusetts.
概括
由于向治疗和免疫治疗,晚期黑色素瘤的存活率显著提高. 目前正在进行的对改造T细胞等新方法的研究旨在进一步降低黑色素瘤死亡率.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 先进的黑色素瘤,一种转移性皮肤癌,已经有了改善的结果.
- 在过去的十年中,第四阶段黑色素瘤的死亡率每年下降3-5%.
- 针对性治疗和免疫治疗的进步推动了这些改进.
研究的目的:
- 审查晚期黑色素瘤治疗的进展情况.
- 突出针对性治疗和免疫疗法的影响.
- 确定黑色素瘤研究的未来方向.
主要方法:
- 对向疗法 (BRAF/MEK 抑制剂) 的审查.
- 对免疫疗法的审查 (免疫检查点阻断剂,T细胞参与剂,TIL疗法).
- 对辅助和新辅助方法的讨论.
主要成果:
- 晚期黑色素瘤患者的结局显著改善.
- 在高达50%的晚期病例中观察到长期持久的反应.
- 降低了II和III阶段黑色素瘤的复发风险,使用辅助/非辅助疗法.
结论:
- 黑色素瘤药物开发正在开创新的癌症研究策略.
- 对复发性,不响应性或罕见的黑色素瘤亚型需要进一步的研究.
- 改性T细胞疗法和了解瘤微环境对未来充满希望.
相关概念视频
01:30Skin Cancer
4.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.6K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:30Cancer Vaccines
523
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
523
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
01:27Tumor Immunotherapy
677
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
677
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K